Cargando…
Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients
Contrast-induced nephropathy (CIN) is a complex syndrome of acute kidney injury that follows exposure to intravascular contrast media. Although a series of preventive measures have been developed, CIN remains a major challenge encountered in elderly patients by interventional cardiologists. No data...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797303/ https://www.ncbi.nlm.nih.gov/pubmed/24137279 http://dx.doi.org/10.3892/etm.2013.1258 |
_version_ | 1782287598821048320 |
---|---|
author | XU, RONG-HE MA, GUI-ZHOU CAI, ZHI-XIONG CHEN, PING ZHU, ZHI-DAN WANG, WEN-LIANG |
author_facet | XU, RONG-HE MA, GUI-ZHOU CAI, ZHI-XIONG CHEN, PING ZHU, ZHI-DAN WANG, WEN-LIANG |
author_sort | XU, RONG-HE |
collection | PubMed |
description | Contrast-induced nephropathy (CIN) is a complex syndrome of acute kidney injury that follows exposure to intravascular contrast media. Although a series of preventive measures have been developed, CIN remains a major challenge encountered in elderly patients by interventional cardiologists. No data are currently available concerning the potential effects of the combined use of hydration and alprostadil in the prevention of CIN following percutaneous coronary intervention (PCI) in elderly patients. Therefore, the aim of the present study was to investigate the ability of a combination of hydration and alprostadil to prevent CIN following PCI in elderly patients. From June 1, 2010 to January 31, 2012, 85 elderly patients undergoing PCI were included in the present study. The included patients were randomly allocated into three groups: the control (22 cases), hydration (28 cases) and hydration + alprostadil (35 cases) group. Serum creatinine (SCr) levels were measured prior to PCI and then daily for 3 days following PCI. Creatinine clearance (Ccr) was also calculated. Following investigation of the incidence of CIN, a significant decline in Ccr was observed in the control group but not in the hydration + alprostadil group after PCI. The reduction in the level of Ccr from baseline in the hydration + alprostadil group was the smallest among the three groups. Moreover, the highest incidence of CIN was in the control group (6 cases, 27.27%), followed by the hydration group (3 cases, 10.71%) and the hydration + alprostadil group (1 case, 2.86%). Therefore, the combined use of hydration and alprostadil significantly reduces the incidence of CIN in elderly patients undergoing PCI. Hydration and alprostadil are suggested to act synergistically to protect renal function. In conclusion, the combined use of hydration and alprostadil is more effective in the prevention of CIN in elderly patients undergoing PCI compared with hydration alone. |
format | Online Article Text |
id | pubmed-3797303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-37973032013-10-17 Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients XU, RONG-HE MA, GUI-ZHOU CAI, ZHI-XIONG CHEN, PING ZHU, ZHI-DAN WANG, WEN-LIANG Exp Ther Med Articles Contrast-induced nephropathy (CIN) is a complex syndrome of acute kidney injury that follows exposure to intravascular contrast media. Although a series of preventive measures have been developed, CIN remains a major challenge encountered in elderly patients by interventional cardiologists. No data are currently available concerning the potential effects of the combined use of hydration and alprostadil in the prevention of CIN following percutaneous coronary intervention (PCI) in elderly patients. Therefore, the aim of the present study was to investigate the ability of a combination of hydration and alprostadil to prevent CIN following PCI in elderly patients. From June 1, 2010 to January 31, 2012, 85 elderly patients undergoing PCI were included in the present study. The included patients were randomly allocated into three groups: the control (22 cases), hydration (28 cases) and hydration + alprostadil (35 cases) group. Serum creatinine (SCr) levels were measured prior to PCI and then daily for 3 days following PCI. Creatinine clearance (Ccr) was also calculated. Following investigation of the incidence of CIN, a significant decline in Ccr was observed in the control group but not in the hydration + alprostadil group after PCI. The reduction in the level of Ccr from baseline in the hydration + alprostadil group was the smallest among the three groups. Moreover, the highest incidence of CIN was in the control group (6 cases, 27.27%), followed by the hydration group (3 cases, 10.71%) and the hydration + alprostadil group (1 case, 2.86%). Therefore, the combined use of hydration and alprostadil significantly reduces the incidence of CIN in elderly patients undergoing PCI. Hydration and alprostadil are suggested to act synergistically to protect renal function. In conclusion, the combined use of hydration and alprostadil is more effective in the prevention of CIN in elderly patients undergoing PCI compared with hydration alone. D.A. Spandidos 2013-10 2013-08-08 /pmc/articles/PMC3797303/ /pubmed/24137279 http://dx.doi.org/10.3892/etm.2013.1258 Text en Copyright © 2013, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Articles XU, RONG-HE MA, GUI-ZHOU CAI, ZHI-XIONG CHEN, PING ZHU, ZHI-DAN WANG, WEN-LIANG Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients |
title | Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients |
title_full | Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients |
title_fullStr | Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients |
title_full_unstemmed | Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients |
title_short | Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients |
title_sort | combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797303/ https://www.ncbi.nlm.nih.gov/pubmed/24137279 http://dx.doi.org/10.3892/etm.2013.1258 |
work_keys_str_mv | AT xuronghe combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients AT maguizhou combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients AT caizhixiong combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients AT chenping combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients AT zhuzhidan combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients AT wangwenliang combineduseofhydrationandalprostadilforpreventingcontrastinducednephropathyfollowingpercutaneouscoronaryinterventioninelderlypatients |